DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover
27 December 2019 - Koblenz, Germany, & Castries, France.
Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS (EPSILOG), based in Castries, France.
EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for nurses and physiotherapists.
The agreed purchase price for EPSILOG amounts to EUR 72m and is subject to further adjustments post-closing. In 2018, EPSILOG had revenues of more than EUR 14 million with an EBITDA of approximately EUR 5 million. EPSILOG's customer base today consists of more than 44,000 providers across the ambulatory market segment.
Closing of the transaction is expected for 27 December 2019.
For further information please refer to:
CompuGroup Medical SE
Head of Investor Relations
27-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||CompuGroup Medical SE|
|Maria Trost 21|
|Phone:||+49 (0)261 8000 6200|
|Fax:||+49 (0)261 8000 3200|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||943855|
|End of Announcement||DGAP News Service|
943855 27-Dec-2019 CET/CEST